Literature DB >> 11147801

The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown.

H Nørrelund1, K S Nair, J O Jørgensen, J S Christiansen, N Møller.   

Abstract

The metabolic response to fasting involves a series of hormonal and metabolic adaptations leading to protein conservation. An increase in the serum level of growth hormone (GH) during fasting has been well substantiated. The present study was designed to test the hypothesis that GH may be a principal mediator of protein conservation during fasting and to assess the underlying mechanisms. Eight normal subjects were examined on four occasions: 1) in the basal postabsorptive state (basal), 2) after 40 h of fasting (fast), 3) after 40 h of fasting with somatostatin suppression of GH (fast-GH), and 4) after 40 h of fasting with suppression of GH and exogenous GH replacement (fast+GH). The two somatostatin experiments were identical in terms of hormone replacement (except for GH), meaning that somatostatin, insulin, glucagon and GH were administered for 28 h; during the last 4 h, substrate metabolism was investigated. Compared with the GH administration protocol, IGF-I and free IGF-I decreased 35 and 70%, respectively, during fasting without GH. Urinary urea excretion and serum urea increased when participants fasted without GH (urea excretion: basal 392 +/- 44, fast 440 +/- 32, fast-GH 609 +/- 76, and fast+GH 408 +/- 36 mmol/24 h, P < 0.05; serum urea: basal 4.6 +/- 0.1, fast 6.2 +/- 0.1, fast-GH 7.0 +/- 0.2, and fast+GH 4.3 +/- 0.2 mmol/1, P < 0.01). There was a net release of phenylalanine across the forearm, and the negative phenylalanine balance was higher during fasting with GH suppression (balance: basal 9 +/- 3, fast 15 +/- 6, fast-GH 17 +/- 4, and fast+GH 11 +/- 5 nmol/min, P < 0.05). Muscle-protein breakdown was increased among participants who fasted without GH (phenylalanine rate of appearance: basal 17 +/- 4, fast 26 +/- 9, fast-GH 33 +/- 7, fast+GH 25 +/- 6 nmol/min, P < 0.05). Levels of free fatty acids and oxidation of lipid decreased during fasting without GH (P < 0.01). In summary, we find that suppression of GH during fasting leads to a 50% increase in urea-nitrogen excretion, together with an increased net release and appearance rate of phenylalanine across the forearm. These results demonstrate that GH-possibly by maintenance of circulating concentrations of free IGF-I--is a decisive component of protein conservation during fasting and provide evidence that the underlying mechanism involves a decrease in muscle protein breakdown.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11147801     DOI: 10.2337/diabetes.50.1.96

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

1.  Effects of short-term application of low-dose growth hormone on trace element metabolism and blood glucose in surgical patients.

Authors:  Kun Qian; Zhi Wan; Lang-Song Hao; Ming-Ming Zhang; Yong Zhou; Xiao-Ting Wu
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 2.  Effects of GH in human muscle and fat.

Authors:  Jens Otto Lunde Jørgensen; Kristine Z Rubeck; Thomas S Nielsen; Berthil F F Clasen; Mikkel Vendelboe; Thomas K Hafstrøm; Michael Madsen; Sten Lund
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

3.  The rise in growth hormone during starvation does not serve to maintain glucose levels or lean mass but is required for appropriate adipose tissue response in female mice.

Authors:  Manuel D Gahete; José Córdoba-Chacón; Raúl M Luque; Rhonda D Kineman
Journal:  Endocrinology       Date:  2012-11-13       Impact factor: 4.736

4.  Adding Glucagon-Stimulated GH Testing to the Diagnostic Fast Increases the Detection of GH-Sufficient Children.

Authors:  Colin P Hawkes; Adda Grimberg; Vivian E Dzata; Diva D De Leon
Journal:  Horm Res Paediatr       Date:  2016-03-17       Impact factor: 2.852

5.  Short-term application of low-dose growth hormone in surgical patients: effects on nitrogen balance and blood glucose.

Authors:  Ming-Ming Zhang; Xiao-Ting Wu; Yong Zhou; Kun Qian; Ya-Min Zheng
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

6.  Impact of growth hormone receptor blockade on substrate metabolism during fasting in healthy subjects.

Authors:  Louise Moller; Helene Norrelund; Niels Jessen; Allan Flyvbjerg; Steen B Pedersen; Bruce D Gaylinn; Jianhua Liu; Michael O Thorner; Niels Moller; Jens Otto Lunde Jorgensen
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

7.  Metabolic response to 36 hours of fasting in young men born small vs appropriate for gestational age.

Authors:  Sine W Jørgensen; Charlotte Brøns; Les Bluck; Line Hjort; Kristine Færch; Ajay Thankamony; Linn Gillberg; Martin Friedrichsen; David B Dunger; Allan A Vaag
Journal:  Diabetologia       Date:  2014-10-07       Impact factor: 10.122

8.  Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load.

Authors:  Thomas Krusenstjerna-Hafstrøm; Michael Madsen; Mikkel H Vendelbo; Steen B Pedersen; Jens S Christiansen; Niels Møller; Niels Jessen; Jens O L Jørgensen
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

9.  Fasting increases human skeletal muscle net phenylalanine release and this is associated with decreased mTOR signaling.

Authors:  Mikkel Holm Vendelbo; Andreas Buch Møller; Britt Christensen; Birgitte Nellemann; Berthil Frederik Forrest Clasen; K Sreekumaran Nair; Jens Otto Lunde Jørgensen; Niels Jessen; Niels Møller
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

10.  Altered metabolism of growth hormone receptor mutant mice: a combined NMR metabonomics and microarray study.

Authors:  Horst Joachim Schirra; Cameron G Anderson; William J Wilson; Linda Kerr; David J Craik; Michael J Waters; Agnieszka M Lichanska
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.